Alcohol Use Disorder and Chronic Pain: An Overlooked Epidemic
- PMID: 38706339
- PMCID: PMC11521207
- DOI: 10.1176/appi.ajp.20230886
Alcohol Use Disorder and Chronic Pain: An Overlooked Epidemic
Abstract
Alcohol use disorder (AUD) and chronic pain disorders are pervasive, multifaceted medical conditions that often co-occur. However, their comorbidity is often overlooked, despite its prevalence and clinical relevance. Individuals with AUD are more likely to experience chronic pain than the general population. Conversely, individuals with chronic pain commonly alleviate their pain with alcohol, which may escalate into AUD. This narrative review discusses the intricate relationship between AUD and chronic pain. Based on the literature available, the authors present a theoretical model explaining the reciprocal relationship between AUD and chronic pain across alcohol intoxication and withdrawal. They propose that the use of alcohol for analgesia rapidly gives way to acute tolerance, triggering the need for higher levels of alcohol consumption. Attempts at abstinence lead to alcohol withdrawal syndrome and hyperalgesia, increasing the risk of relapse. Chronic neurobiological changes lead to preoccupation with pain and cravings for alcohol, further entrenching both conditions. To stimulate research in this area, the authors review methodologies to improve the assessment of pain in AUD studies, including self-report and psychophysical methods. Further, they discuss pharmacotherapies and psychotherapies that may target both conditions, potentially improving both AUD and chronic pain outcomes simultaneously. Finally, the authors emphasize the need to manage both conditions concurrently, and encourage both the scientific community and clinicians to ensure that these intertwined conditions are not overlooked given their clinical significance.
Keywords: Alcohol; Alcohol Intoxication; Alcohol Use Disorder; Alcohol Withdrawal; Analgesics; Chronic Pain; Pain; Pain Measurement; Substance-Related and Addictive Disorders.
Conflict of interest statement
Dr. De Aquino has received in-kind medication support for clinical trials from Jazz Pharmaceuticals and has served as a consultant for Boehringer Ingelheim. Dr. Petrakis has received in-kind medication support for research studies from Alkermes and BioXcel Therapeutics and is co-editor of the
Figures



References
-
- SAHMSA: Key Substance Use and Mental Health Indicatorsin the United States: Results from the 2022 National Survey on Drug Use and Health (HHS Publication No. PEP23–07-01–006, NSDUH Series H-58). Rockville, MD, Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2023
-
- Sheu R, Lussier D, Rosenblum A, et al.: Prevalence and characteristics of chronic pain in patients admitted to an outpatient drug and alcohol treatment program. Pain Med 2008; 9:911–917 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical